F. Gebhard et al., SYSTEMIC RELEASE OF PROSTANOIDS AFTER SURGERY-INDUCED LUNG-TISSUE INJURY, Langenbecks Archiv fur Chirurgie, 382(5), 1997, pp. 243-251
In a prospective study, the systemic inflammatory consequences of surg
ery-induced lung tissue injury were evaluated using biochemical marker
s. The aim was to examine whether this type of injury produces a speci
fic pattern of prostanoid plasma levels (prostacyclin, thromboxane, PG
E(2), PGF(2 alpha), and PGM). We, therefore, compared 18 patients (gro
up 1)who underwent thoracotomy without injury to the lung with 26 pati
ents (group 2) that had a resection of pulmonary tissue due to benign
diseases. Group 2 patients clearly revealed increased plasma levels of
C-reactive protein as well as of the granulocyte-specific PMN-elastas
e. In particular, there was a pronounced release of prostacyclin and i
ts antagonist thromboxane A(2) following lung tissue resection. In con
trast to group 1 patients, lung tissue damage resulted in immediately
elevated plasma levels of PGF(2 alpha) and PGE(2). When, however, taki
ng into account the timecourse of PGM, the stable cleavage product of
PGF(2 alpha), there was no hint of an altered pulmonary metabolic capa
city. Presumably, this pattern of elevated prostanoid levels in group
2 is the result of the surgical damage to the lung tissue. Therefore,
it can be suggested to be specific for that type of injury. Thus, the
release of prostanoids following surgery-induced lung tissue damage ma
y indicate the importance of these mediators, particularly in thoracic
injuries associated with lung damage since those may lead to post-tra
umatic pulmonary dysfunction. These substances may also be useful in e
valuating both the severity and the extent of lung tissue damage follo
wing major trauma.